Thrombotic microangiopathy (TMA) is a rare but lethal multisystem disease characterized by peripheral thrombocytopenia, microangiopathic hemolytic anemia, fever, and various stages of renal and neurological dysfunctions.1,2) The causes of TMA are mainly thrombotic thrombocytopenic purpura (TTP) or hemolytic-uremic syndrome (HUS), and cases of TMA related to myelodysplastic syndrome (MDS) are quite rare. Herein, we report a case of acute myocardial infarction (AMI) caused by TMA which is strongly suspected to have a relationship to MDS, and discuss the treatment of our patient who needed antiplatelet or anticoagulant therapy after AMI, while on the other hand, had pancytopenia and a bleeding event due to MDS.
CITATION STYLE
Oshima, T., Ikutomi, M., Shinohara, H., Ishiwata, J., Fukino, K., Amaki, T., & Nakamura, F. (2016). Acute myocardial infarction caused by thrombotic microangiopathy complicated with myelodysplastic syndrome. International Heart Journal, 57(5), 634–636. https://doi.org/10.1536/ihj.16-100
Mendeley helps you to discover research relevant for your work.